Recent Updates
Recently added Catalysts
QGEN Positive Sentiment Score: 60/100

QIAGEN N.V. to release results for Q2 2023 and hold webcast

Monday, July 24, 2023 2 min read
Key Takeaway: QIAGEN N.V. is set to release its Q2 2023 results on August 8, 2023. This announcement is accompanied by a conference call scheduled for August 9, where stakeholders can join to discuss the results. The company emphasizes its role as a leading provider of Sample to Insight solutions in molecular diagnostics and life sciences, catering to over 500,000 customers globally.

Market Sentiment Analysis

POSITIVE FACTORS

  • QIAGEN is announcing results for Q2 2023, indicating ongoing business progress.
  • The scheduled conference call reflects the company's commitment to transparency with investors.
  • QIAGEN’s diversified solutions for molecular insights enhance its market position.

Full Press Release Details

Venlo, The Netherlands, July 24, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter 2023.
Press release date / time: Tuesday, August 8, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.
Conference call date / time: Wednesday, August 9, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.
Three options for joining the conference call
1.Register for call back connection - Click here: Connect me
Service available 15 minutes before call start
U.S.: +1 646 828 8193
UK: +44 (0)330 165 3655
GER: +49 (0)69 6610 2490
Conference ID: 4878029
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
3. Access the audio webcast - Click here: Access Webcast
A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1596354&tp_key=0acb730754
Contact: IR@qiagen.com
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to
Insight solutions that enable customers to gain valuable molecular insights from samples containing
the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from
blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for
analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable
insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN
provides solutions to more than 500,000 customers around the world in Molecular Diagnostics
(human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily
forensics). As of March 31, 2023, QIAGEN employed more than 6,200 people in over 35 locations
worldwideFurther information can be found at http://www.qiagen.com.

Contact Data

Contact

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.

Frequently Asked Questions

When will QIAGEN announce its Q2 2023 results?

QIAGEN will release its Q2 2023 results on August 8, 2023.

What is the date for the QIAGEN conference call?

The conference call is scheduled for August 9, 2023.

How can I join the QIAGEN conference call?

Participants can join via call back, phone numbers, or audio webcast.

What time is the QIAGEN conference call?

The call starts at 15:00 Frankfurt time on August 9.

What services does QIAGEN provide?

QIAGEN offers solutions for molecular insights from various sample types.

Tags: QGEN Viatris Investor Conferences Healthcare QIAGEN Q2 2023 molecular diagnostics webcast
Last updated: Jul 24, 2023